Grifols (GIKLY) Change in Working Capital (2010 - 2020)

Grifols (GIKLY) posted Change in Working Capital of -$66.3 million for Q1 2020, down 226.55% quarter-over-quarter from $52.4 million in Q4 2019, and down 90.98% year-on-year from -$735.3 million in Q2 2019.

Grifols (GIKLY) Change in Working Capital (2010 - 2020) Analysis & Trends

Grifols (GIKLY) has reported Change in Working Capital for 10 consecutive years, with -$66.3 million the latest figure, recorded in Q1 2020.

  • Change in Working Capital for Q1 2020 came in at -$66.3 million, down 90.98% year-over-year; the trailing twelve-month figure through Mar 2020 was -$50.8 million (down 180.44% YoY), and the FY2025 annual result was $36.1 million, down 95.46% from the prior year.
  • Change in Working Capital was -$66.3 million for Q1 2020 at Grifols, down from $52.4 million in the prior quarter.
  • Over five years, Change in Working Capital peaked at $179.9 million in Q2 2017 and troughed at -$66.3 million in Q1 2020.
  • Average Change in Working Capital over 5 years is $34.0 million, with a median of $43.0 million recorded in 2016.
  • The widest YoY moves for Change in Working Capital: up 2571.89% in 2019, down 391.37% in 2019.
  • Over 5 years, Change in Working Capital stood at $52.9 million in 2016, then jumped by 34.75% to $71.3 million in 2017, then sank by 102.97% to -$2.1 million in 2018, then soared by 2571.89% to $52.4 million in 2019, then plunged by 226.55% to -$66.3 million in 2020.
  • Per Business Quant data, the three most recent Change in Working Capital figures were -$66.3 million in Q1 2020, $52.4 million in Q4 2019, and -$34.7 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Working Cap. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 7.51 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -787.00 Mn
10 Grifols - - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -66.31 Mn
Mar 31, 2020 -66.31 Mn
Dec 31, 2019 52.39 Mn
Dec 31, 2019 52.39 Mn
Mar 31, 2019 -34.72 Mn
Mar 31, 2019 -34.72 Mn
Dec 31, 2018 -2.12 Mn
Dec 31, 2018 -2.12 Mn
Jun 30, 2018 88.02 Mn
Jun 30, 2018 88.02 Mn
Mar 31, 2018 11.92 Mn
Mar 31, 2018 11.92 Mn
Dec 31, 2017 71.33 Mn
Dec 31, 2017 71.33 Mn
Jun 30, 2017 179.86 Mn
Jun 30, 2017 179.86 Mn
Mar 31, 2017 -22.48 Mn
Mar 31, 2017 -22.48 Mn
Dec 31, 2016 52.93 Mn
Dec 31, 2016 52.93 Mn